Aqua Bio Technology ASA

BST:3FZ Stock Report

Market Cap: €30.3m

Aqua Bio Technology Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Aqua Bio Technology's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals Industry Growth12.4%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Next Earnings Update12 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Aqua Bio Technology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BST:3FZ Revenue, expenses and earnings (NOK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2314-2200
31 Mar 2310-10180
31 Dec 227-19170
30 Sep 224-20180
30 Jun 222-22180
31 Mar 222-21180
31 Dec 212-19180
30 Sep 212-18170
30 Jun 211-18170
31 Mar 211-16160
31 Dec 201-15160
30 Sep 201-13140
30 Jun 201-11120
31 Mar 201-12120
31 Dec 191-13130
30 Sep 191-26140
30 Jun 191-38160
31 Mar 191-38160
31 Dec 181-38170
30 Sep 181-30170
30 Jun 182-22180
31 Mar 186-19200
31 Dec 1710-16220
30 Sep 1722-6220
30 Jun 1733-4230
31 Mar 1741-3280
31 Dec 16491290
30 Sep 16475270
30 Jun 164613270
31 Mar 164217200
31 Dec 153917170
30 Sep 153411170
30 Jun 153010150
31 Mar 15265160
31 Dec 14221160
30 Sep 1421-2170
30 Jun 1419-4170
31 Mar 14210150

Quality Earnings: 3FZ has a high level of non-cash earnings.

Growing Profit Margin: Insufficient data to determine if 3FZ's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 3FZ's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare 3FZ's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if 3FZ's earnings growth over the past year exceeded the Chemicals industry average.

Return on Equity

High ROE: 3FZ has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 15:19
End of Day Share Price 2025/01/17 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aqua Bio Technology ASA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tomas SkeivysNorne Securities AS